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A B S T R A C T   
This study aimed to examine the effects of Cacna1a mutation on the phenotype of Scn1a-associated epilepsy in 
rats. We used rats with an N1417H missense mutation in the Scn1a gene and others with an M251K mutation in 
the Cacna1a gene. Scn1a/Cacna1a double mutant rats were generated by mating both Scn1a and Cacna1a mu-
tants. We investigated general health and the epileptic phenotype in all these genotypes. The onset threshold of 
hyperthermia-induced seizures was examined at 5 weeks and spontaneous seizures were monitored using video- 
EEG recordings from 6 to 12 weeks of age. Scn1a/Cacna1a double mutants showed significantly reduced 
threshold for hyperthermia-sensitive seizures onset compared with the Scn1a mutants and had absence seizures 
having 6–7 c/s spike-wave bursts with changes in the spike-wave pattern, whereas Cacna1a mutants had regular 
6–7 c/s spike-wave bursts. In Scn1a/Cacna1a double mutants, 6–7 c/s spike-wave bursts were accompanied with 
eyelid myoclonia and continuously shifting generalized clonic seizures, which were not observed in either Scn1a 
or Cacna1a mutants. Although a curvature of the spine was observed in rats of all these genotypes, the degree of 
curvature was more pronounced in Scn1a/Cacna1a double mutants, followed by Cacna1a and Scn1a mutants. 
Our results indicate that Cacna1a and Scn1a mutations mutually alter their original phenotypes in rats. The 
phenotype of absence seizures with eyelid myoclonia, generalized clonic seizures, and of spine curvature in the 
Scn1a/Cacna1a double mutants were similar to that observed in patients with Dravet syndrome.   
1. Introduction 
Mutations in the SCN1A gene, which encodes the voltage-gated so-
dium channel Nav1.1, cause a spectrum of epileptic disorders ranging 
from a benign form of genetic epilepsy with febrile seizure plus (GEFS+) 
to an intractable form of Dravet syndrome (Catterall et al., 2010; Oliva 
et al., 2012). The type of SCN1A and mosaic variants impact epileptic 
severity (Zuberi et al., 2011; de Lange et al., 2018). Frameshift, 
nonsense, and nonfunctional missense mutations have mostly been re-
ported in patients with Dravet syndrome, while missense mutations with 
residual function of the protein have often been reported in GEFS +
patients (Harkin et al., 2007). However, it remains unclear as to why 
similar pathogenic SCN1A mutations cause a spectrum of phenotypes. 
One explanation is the presence of genetic modifiers, which are a 
common feature of monogenic diseases with variable clinical pheno-
types among individuals with the same mutation. Indeed, previous 
studies have investigated genetic modifiers to better understand the 
underlying mechanism and severity prediction of GEFS+ and Dravet 
syndrome (Singh et al., 2009; Gaily et al., 2013; Ohmori et al., 2008, 
2013; Hammer et al., 2017). 
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Genetic impact on epileptic phenotype using genetically modified 
animal models is clearer than using human subjects. Several studies 
have shown that certain modifier genes significantly alter the phenotype 
of the Scn1a mutation. Scn1a knockout (KO) and knockin (KI) mice with 
a nonsense Scn1a mutation, which are mouse models of Dravet syn-
drome, exhibited strong strain-dependent differences in phenotypic 
severity (Yu et al., 2006; Ogiwara et al., 2007). Using RNA-sequencing 
analysis of strain-dependent gene expression, several potential candi-
date modifier genes have been previously reported (Miller et al., 2014). 
They include γ-aminobutyric acid (GABA) receptor subunit genes, the 
calcium channel subunit genes Cacna1a and Cacna2d1, the chloride 
channel gene Clcn3, the potassium channel gene Kcnj11, and the Na+/K 
+ -ATPase gene Atp1a3 (Miller et al., 2014). Abnormalities of two 
molecules in the same pathway could aggravate each phenotype. We 
have previously observed that both Nav1.1, encoded by Scn1a, and 
Cav2.1 encoded, by Cacna1a, express the parvalbumin-positive 
GABAergic interneurons (Ogiwara et al., 2007; Jiang et al., 2016). The 
underlying pathology of SCN1A-associated epilepsy lies behind the 
dysfunction of GABAergic interneurons (Yu et al., 2006; Ogiwara et al., 
2007). Therefore, we hypothesized that a Cacna1a mutation may be an 
exacerbating factor for Scn1a mutation-associated epilepsy. Herein, we 
examined the effects of a Cacna1a mutation on the phenotype of 
Scn1a-associated epilepsy in a rat model of GEFS+. 
2. Materials and methods 
2.1. Animals 
We used F344/NSlc-Scn1a Kyo811 rats with a homozygous N1417H 
missense mutation in the Scn1a gene, henceforth referred to as Scn1a 
mutant rats, and GRY/Idr rats with a homozygous M251K mutation in 
the Cacna1a gene, henceforth referred to as Cacna1a mutant rats. 
N1417H-Scn1a and M251K-Cacna1a mutations are found in the pore 
regions of voltage-gated channels, which are highly selective for per-
meant cations such as sodium and calcium. Pore-missense mutations 
have been linked to human channelopathy due to alternation in elec-
trophysiological properties (Catterall et al., 2010, Simms and Zamponi, 
2014). The original strains of Scn1a and Cacna1a mutant rats were 
F344-NSlc and Wistar, respectively. Cacna1a mutant rats were repeat-
edly crossed with wild type (WT) F344/NSlc rats (Nippon SLC, Hama-
matsu, Japan) for more than 15 generations to minimize the impact of 
strain-specific genetic differences on the phenotype. After back-
crossing Cacna1a mutant Wistar rats to WT F344/NSlc rats, the resultant 
heterozygous M251K-Cacna1a mutant offspring were mated with ho-
mozygous Scn1a mutant rats to generate Scn1a/Cacna1a double mutant 
rats. Interbreeding of these double mutant rats generated offspring 
carrying the homozygous N1417H-Scn1a and homozygous 
M251K-Cacna1a mutations. 
Scn1a mutant rats exhibited susceptibility to hyperthermia-induced 
seizure (Mashimo et al., 2010). Hippocampal neurons of Scn1a mutant 
rats demonstrated impaired biophysical properties of inhibitory 
GABAergic neurons (Mashimo et al., 2010). 
Cacna1a mutant rats exhibited ataxia and absence seizures from 6 
weeks of age (Tokuda et al., 2007). In acutely dissociated Purkinje cells 
of Cacna1a mutant rats, the high-voltage-activated Ca2+ channel, 
Cav2.1, showed an increased current density and a depolarizing shift in 
the activation and inactivation curves compared with those of WT rats 
(Tanaka et al., 2007). 
In this study, we examined four groups: WT rats, Scn1a mutant rats 
with a homozygous N1417H mutation (Scn1a mutants), Cacna1a mutant 
rats with a homozygous M251K mutation (Cacna1a mutants), and 
double mutant rats with a double homozygous N1417H-Scn1a and 
M251K-Cacna1a mutation (Scn1a/Cacna1a double mutants). 
Rats were maintained under standard laboratory conditions with a 
12-h light/dark cycle and food and water ad libitum. Animal experiments 
were performed in accordance with protocols approved by the 
Institutional Animal Care and Use Committee of Okayama University. 
The 3R (replacement, reduction, and refinement) concept was consid-
ered when planning the experiments. 
2.2. Genotyping 
At 3 weeks of age, DNA was extracted from the tail snips with DNeasy 
Blood & Tissue kit (Qiagen). The fragment of interest with the mutation 
was amplified with a pair of primers as follows: Scn1a-sense 5′- 
TGACTTTTCTTTCTCTCCGTTTG-3′and Scn1a-antisense 5′- 
TGGCTGCAATAATCACTTTGTT-3′ for the N1417H-Scn1a mutation and 
Cacna1a-sense 5′-TCTCTGTCTCCCCAGGTTTAC-3′ and Cacna1α-anti-
sense 5′-GTGGCTAACACACAGCTTTGC-3′ for the M251K-Cacna1α mu-
tation. Resultant PCR products (380 bp for Scn1a and 350 bp for 
Cacna1a) were digested with BclI and PsiI restriction enzymes, respec-
tively. The genotype was determined using the size of the digested 
fragments on a 3% agarose gel. Scn1a fragment of 380 bp was divided 
into two fragments of 276 bp and 104 bp if it had a mutation. Cacna1a 
fragment of 350 bp was divided into two fragments of 220 bp and 130 bp 
if it had a mutation (Supplementary Fig. 1). 
2.3. General health 
Body weight was measured at 6, 8, 10, and 12 weeks of age in WT 
controls, Scn1a mutants, Cacna1a mutants, and double mutant rats. An 
X-ray examination (MBR-1520R-3, HITACHI) and a computed tomog-
raphy (CT) scan (LaTheta LCT-200, HITACHI ALOKA) of the skeletal 
structure was performed in 9-month old rats (two rats per genotype) 
under pentobarbital sodium anesthesia or vaporized isoflurane. 
2.4. Video-electroencephalogram recordings 
The rats were implanted with electrodes for electroencephalogram 
(EEG) recordings as previously described (Hayashi et al., 2011). 
Following a recovery period of at least 1 week, hyperthermia-induced 
seizures, absence seizures, and spontaneous seizures were recorded 
through a video-EEG (Neurofax EEG-1200, Nihon Kohden). 
2.5. Hyperthermia-induced seizures 
We evaluated hyperthermia-induced seizures in Scn1a mutants and 
Scn1a/Cacna1a double mutants to compare and examine the effects of 
the additional Cacna1a mutation in Scn1a mutant rats. Hyperthermia- 
induced seizures were induced by placing rats in a water bath filled 
with hot water at 45 ◦C as described previously (Hayashi et al., 2011). 
2.6. Absence seizures 
The total duration of spike-wave discharges were assessed for 60 min 
in wake EEG recordings and in a single seizure duration at 6, 8, 10, and 
12 weeks of age. Based on the absence seizures’ frequency in these rats, a 
60-min duration was deemed appropriate to evaluate the associated 
severity. Number of rats used per group is shown in supplementary table 
1. 
2.7. Spontaneous seizures other than absence seizures 
For assessment of spontaneous seizures in the three mutant geno-
types (Scn1a mutants, Cacna1a mutants, and double mutant rats), long- 
term video-EEG recordings were collected in 13–15-h overnight sessions 
(regularly from 6:00 p.m. to 9:00 a.m.), once every 2 weeks for up to 12 
weeks of age (Supplementary Table 1). 
2.8. Statistical analysis 
All data are presented as the mean ± SD (standard deviation) and 
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reported as significant at P < 0.05. Data were compared using a paired t- 
test. 
3. Results 
3.1. General health and skeletal abnormality 
The growth curve from 6 to 12 weeks of age for each genotype is 
shown in Fig. 1A. Cacna1a mutants and Scn1a/Cacna1a double mutants 
exhibited diminished growth with a body weight significantly lower 
than that of WT rats (P < 0.001). There was no significant difference in 
body weight between WT rats and Scn1a mutants (P = 0.16). Cacna1a 
mutants and Scn1a/Cacna1a double mutants showed different neuro-
logical phenotypes including hypotonia, wide based hindlimb position, 
and ataxic gait. Since these two groups were inactive during an exper-
imental apparatus, no behavioral evaluation was conducted. 
During the breeding of experimental rats, we observed an excessive 
spinal curvature in older Cacna1a mutants; therefore, we examined 
skeletal abnormalities in 9-month old rats using X-ray and CT scan. 
Cacna1a mutants and Scn1a/Cacna1a double mutants exhibited exces-
sive spinal curvature between the cervical and thoracic vertebrae 
(Fig. 1B and C). Scn1a mutants showed a mild spinal curvature. Scn1a/ 
Cacna1a double mutants tended to have a more severe spinal curvature 
compared to Cacna1a mutants. 
3.2. Impact of Cacna1a mutation on hyperthermia-induced seizures 
Scn1a mutants exhibit susceptibility to hyperthermia-induced 
seizure. WT and Cacna1a mutants did not develop hyperthermia- 
induced seizures in this study. To evaluate the possible impact of Cac-
na1a mutation on hyperthermia-induced seizures, we compared the la-
tency to seizure onset, rectal temperature at seizure onset, and seizure 
duration between Scn1a mutants and Scn1a/Cacna1a double mutants. 
The time interval until a seizure occurred after placing a double mutant 
rat in hot water (45 ◦C) was significantly shorter than that observed for 
Scn1a mutants (Fig. 2A; Scn1a mutants, 222.6 ± 5.3 s vs. Scn1a/Cacna1a 
double mutants, 146.0 ± 17.5 s, P < 0.01). The rectal temperature at the 
time of seizure in double mutants rats was significantly lower than that 
in Scn1a mutants (Fig. 2B; Scn1a mutant rats, 43.4 ± 0.07 ◦C vs. Scn1a/ 
Cacna1a double mutant rats, 42.4 ± 0.19 ◦C, P < 0.01). These results 
indicate that the threshold of hyperthermia-induced seizure onset in 
Scn1a/Cacna1a double mutant rats is lower than that in Scn1a mutants. 
Seizure duration was longer in Scn1a/Cacna1a double mutants 
compared to Scn1a mutants, though statistically insignificant (Fig. 2C; 
Scn1a mutants, 64.7 ± 8.0 s vs. Scn1a/Cacna1a double mutants, 82.6 ±
17.4 s, P = 0.42). The generalized tonic-clonic seizure and EEG patterns 
were similar in the two groups (Fig. 2D and E). 
3.3. Impact of Scn1a mutation on absence seizures caused by Cacna1a 
mutation 
We recorded EEGs for 60 min in Cacna1a mutants and Scn1a/Cac-
na1a double mutants at 6, 8, 10, and 12 weeks of age. We previously 
demonstrated that Scn1a mutants had not absence seizures by using a 
long-term video-EEG monitoring, (Ohmori et al., 2014). 
The total duration of absence seizure between the two groups was 
not significantly different (Fig. 3A), whereas differences in ictal EEG 
patterns of absence seizure were observed. At 6 weeks of age, 6–7 c/s 
(cycles per second) spike-and-wave bursts were regular in both groups 
(Fig. 3B and C). At 10 weeks of age, the ictal EEG pattern in Cacna1a 
mutants was the same as that at 6 weeks (Fig. 3D), while patterns in 
Scn1a/Cacna1a double mutants often exhibited a change from the reg-
ular 6–7 c/s spike-wave bursts to a gradually slowing pattern in the 
latter half, as shown in Fig. 3E. 
3.4. New type of seizures in Scn1a/Cacna1a double mutant rats 
Scn1a/Cacna1a double mutants exhibited new types of spontaneous 
seizures that have never been observed in either Scn1a or Cacna1a single 
mutants. In double mutants, absence seizures were accompanied with 
myoclonic components involving the eyelids and limbs (Fig. 4A, Video 
1). Some spike-and-wave bursts sequentially developed to generalized 
clonic seizures (Fig. 4B, Video 2). Myoclonic jerks accompanied with 
polyspikes on EEGs were also detected (Fig. 4C, Video 3). Generalized, 
Fig. 1. Comparison of growth curves and skeletal malformations. The body weight of rats (WT, n = 10; Scn1a mutants, n = 10; Cacna1a mutants, n = 12; Scn1a/ 
Cacna1a double mutants, n = 10) was measured from 6 weeks to 12 weeks of age. The skeletal structure was evaluated by X-ray examination and a computed 
tomography scan in 9-month old rats (n = 2 per genotype); **P < 0.01. 
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Fig. 2. The threshold of hyperthermia-induced seizures is lowered in Scn1a/Cacna1a double mutants. (A) The time to onset of a seizure after placing rats in hot water 
(45 ◦C). (B) Rectal temperature at the onset of hyperthermia-induced seizure and (C) the seizure duration. Scn1a mutants, n = 10; double mutant, n = 13; **P < 0.01. 
(D) and (E) demonstrate representative EEG patterns of hyperthermia-induced seizures in Scn1a mutants and in double mutant rats, respectively. 
Fig. 3. The pattern of spike-and-wave discharges in Scn1a/Cacna1a double mutants is altered. (A) The total seizure duration was measured for 60 min in Cacna1a 
mutants and Scn1a/Cacna1a double mutants at 6, 8, 10, and 12 weeks of age. A representative EEG pattern of absence seizure showed regular spike-and-wave 
discharges in Cacna1a mutants (B) and in Scn1a/Cacna1a double mutants at 6 weeks of age (C); and in Cacna1a mutants at 10 weeks of age (D). (E) The ictal 
EEG pattern of Scn1a/Cacna1a double mutants at 10 weeks of age showed slowing cycles of spike-and-wave discharges. Black dots indicate regular cycles of spike- 
and-wave discharges. Red dots indicate slowing cycles of spike-and-wave discharges. 
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sudden, clonic seizures were observed twice at 12 weeks of age (Fig. 4D, 
Video 4). The seizure types observed for each genotype are summarized 
in Table 1. 
Supplementary video related to this article can be found at https 
://doi.org/10.1016/j.neuint.2020.104859 
Fig. 4. Ictal EEG of spontaneous seizures in 
double mutant rats. (A) The rat was 
motionless with half-closed eyelids accom-
panied by a 6 c/s (cycles per second) spike- 
wave discharges on an EEG. Blinking and 
myoclonic jerks appeared in the latter half of 
the seizures (black border). (B) The 6 c/s 
spike-and-wave discharges began to appear 
during sleep. These discharges continuously 
developed big spikes with a slower cycle. A 
jerk of the head appeared at the time-point 
indicated by the arrow, followed by gener-
alized clonic seizures. The rat stood up and 
thrashed its forelimbs, while opening and 
shutting the mouth, like oral automatism. 
(C) Myoclonic seizures and (D) generalized 
clonic seizures appeared at 12 weeks of age. 
Sleeping rats had a jerk accompanied by 
polyspikes on an EEG (C). The sleeping rat 
suddenly had a jerk of the head followed by 
clonic movements of the forelimbs. An ictal 
EEG showed a burst of spikes and big sharp 
waves with gradually increasing amplitude.   
Table 1 











Scn1a mutants + none none none none 
Cacna1a mutants none + none none none 
Scn1a/Cacna1a double 
mutants 
++ + + + +
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4. Discussion 
4.1. Hyperthermia-sensitive seizures 
In Dravet syndrome, epileptic seizures are easily triggered by fever. It 
remains unclear as to why Cacna1a mutation lowers the threshold of 
hyperthermia-sensitivity seizures. The molecular mechanisms linking 
SCN1A mutations with hyperthermia-sensitive seizures are also largely 
unknown. The temperature-dependent electrophysical properties of re-
combinant epilepsy-associated SCN1A missense mutation gene product 
are different from those for the WT SCN1A gene product (Peters et al., 
2016), which partly explains the hyperthermia-sensitivity of mutant 
SCN1A. However, approximately half SCN1A mutations found in pa-
tients with Dravet syndrome are truncating mutations that result in a 
nonfunctional gene product, while the remaining are missense muta-
tions that often lead to complete loss of function (Catterall et al., 2010; 
Ohmori et al., 2006). Thus, it is unlikely that only biophysical alterations 
of the voltage-gated sodium channel Nav1.1, encoded by SCN1A, in 
response to hyperthermia are responsible for the hyperthermia-sensitive 
seizures in Dravet syndrome. An electrophysiological study using neu-
rons from mutant animals or cells derived from patients with Dravet 
syndrome may be helpful to understand the mechanism and exacerba-
tion factors of hyperthermia-sensitive seizures. 
4.2. Absence seizures with mioclonia and clonic seizures 
Some patients with Dravet syndrome exhibit absence seizures with 
myoclonia (Dravet, 2011). However, to date, absence seizures and 
myoclonic seizures have not been reported in Darvet syndrome mice 
models, Scn1a KO mice, or Scn1a mutants (Yu et al., 2006; Ogiwara 
et al., 2007; Ohmori et al., 2014). The absence seizures in double mutant 
rats are characterized by 6–7 c/s bursts associated with eyelid myoclo-
nia and a transition to clonic convulsions. To our knowledge, no animal 
models of absence epilepsy exhibiting these phenomena have been re-
ported to date. Absence seizures in patients with Dravet syndrome are 
characterized by frequent association of eyelid myoclonia and general-
ized myoclonia (Dravet, 2011; Tsuda et al., 2013). When the myoclonic 
component is pronounced, it is difficult to differentiate absence seizures 
from myoclonic seizures, since both are considered the same epileptic 
phenomena with different intensity and duration (Dravet, 2011). The 
characteristics of absence seizures observed in double mutant rats are 
similar to those observed in patients with Dravet syndrome. A recent 
study of whole exome sequencing in 87 patients with SCN1A-related 
epilepsy suggested potential modifying associations in genes such as 
SCN8A, POLG, SCN2A, CACNA1A, and CACNA1G, in several patients 
who carried variants in these genes (de Lange et al., 2020). Further 
studies are warranted to determine whether absence seizures and 
myoclonic seizures are associated with other modifier genes in patients 
with Dravet syndrome. 
4.3. Orthopedic abnormality 
We first observed that Cacna1a mutants began displaying curvature 
of the spine with increasing age. Although differences in spinal curva-
ture were not significant as measured by X-ray and CT scan, it was 
visually more pronounced in the Cacna1a mutant group than in the 
Scn1a mutant group, while the double mutants had maximum spinal 
curvature. The progressive crouching gait in patients with Dravet syn-
drome has attracted significant attention (Rilstone et al., 2012; Rodda 
et al., 2012). Currently, two hypotheses have been proposed to explain 
the cause of gait disturbance (Kalume et al., 2007; Fasano et al., 2014). 
The hypothesis that gait disturbance is caused by cerebellar dysfunction 
is supported by experimental results in Scn1a KO mice (Kalume et al., 
2007). NaV1.1 channels are expressed in cerebellar Purkinje neurons, 
which firing rates in Scn1a KO mice are substantially reduced (Kalume 
et al., 2007). Cav2.1 channels are also expressed on Purkinje cells and 
play a critical role for neurotransmitter release (Mori et al., 1991). Gait 
disturbance can be exacerbated by Scn1a and Cacna1a double damage in 
the sequential excitation process of Purkinje neurons. The alternative 
hypothesis is that gait disturbance in adults is a symptom of parkisonism 
rather than cerebellar ataxia. Treatment with levodopa has been re-
ported to improve parkisonism and antecollis conditions in patients with 
Dravet syndrome (Fasano et al., 2014). We have previously reported a 
significantly lower level of dopamine in the striatum in Scn1a mutant 
rats compared to that in WT (Ohmori et al., 2014), partially supporting 
the parkinsonism-caused gait disturbance in Dravet syndrome 
hypothesis. 
4.4. Scn1a and Cacna1a share the same physiological pathway 
Exacerbation of symptoms linked to Scn1a and Cacna1a mutations 
may be attributed to the same physiological pathway, since both Nav1.1 
and Cav2.1 are expressed in parvalbumin-positive GABAergic in-
terneurons (Yu et al., 2006; Ogiwara et al., 2007; Jiang et al., 2016) and 
cerebellar Purkinje cells (Kalume et al., 2007; Mori et al., 1991). A 
positron emission tomography study using flumazenil, a selective 
GABA-A receptor ligand, reported GABA-A receptor impairment in pa-
tients with CACNA1A mutations (Kono et al., 2014). GABA-A receptor 
dysfunction in the cerebral cortex was also reported in an animal model 
with a Cacna1a mutation (Tehrani et al., 1997). A Cacna1a mutation 
causes a decrease in GABAergic neuronal activity attributed to GABA-A 
receptor dysfunction. Several candidate modifier genes were reported in 
a mouse model of Dravet syndrome included genes encoding for GABA-A 
receptor, voltage-gated calcium channels, and the Na+/K+-ATPase, 
ATP1A3 (Miller et al., 2014). SCN1A, CACNA1A, and ATP1A3 are 
causative genes of hemiplegic migraine and cerebellar ataxia (Dichgans 
et al., 2005; Ducros et al., 1999; Potic et al., 2015; Holm and 
Lykke-Hartmann, 2016). ATP1A3 is primarily expressed in GABAergic 
neurons (Bøttger et al., 2011). Defective ATPases may cause sodium and 
potassium ions leakage across the cell membrane, reducing neuronal 
excitability. These findings suggest that SCN1A, CACNA1A, and 
ATP1A3A share same physiological function, specifically when 
expressed in the same type of neurons or neuronal circuit. 
5. Conclusions 
Herein, we showed that Cacna1a and Scn1a mutations mutually alter 
the phenotype of single mutant Scn1a and Cacna1a epileptic rats, 
respectively. The Cacna1a mutation lowers the threshold of 
hyperthermia-sensitive seizures in Scn1a mutants, while Scn1a mutation 
adds myoclonic components to absence seizures in Cacna1a mutants. 
Orthopedic abnormality was observed in Scn1a, Cacna1a, and Scn1a/ 
Cacna1a double mutants, while the degree of spinal curvature was the 
most pronounced in Scn1a/Cacna1a double mutants. Exacerbation of 
symptoms linked to Scn1a and Cacna1a mutations may share the same 
pathway. Using next-generation sequencing, large amounts of genetic 
data can be easily, and cost effectively, obtained, which will help to 
better manage epilepsy. Identifying modifier genes, associated with 
absence seizures or gait disturbance in Dravet syndrome, will help with 
more accurate prognosis and treatment strategy. 
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